Category: Hiv aids treatment

Nelfinavir, an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection, was first approved by the FDA in 1997. The generic for nelfinavir is known by its chemical name, nelfinavir mesylate, but a therapeutically equivalent generic version is currently not available in the United States.

In a 2012 study, researchers found that for each year HIV-positive patients took the tenofovir disoproxil fumarate (TDF) contained in Truvada, their risk of chronic kidney disease increased by 33%. This has led many to question: **Does Truvada affect the kidneys?**. The answer is yes, particularly with long-term use, and understanding this impact is crucial for patient care and monitoring.

Approved by the FDA in 2006, Atripla was once considered a game-changer as the first complete single-tablet regimen for HIV treatment. For those currently taking it or researching options, questions have arisen because the brand name is no longer actively marketed. Is Atripla discontinued, and what does this mean for patients managing HIV?.

According to patient reports, a significant factor in tolerating HIV medication is managing side effects, such as insomnia. Determining the best time to take acriptega, a common antiretroviral, depends on how your body reacts to its active ingredients and what routine you can stick to consistently.

First approved by the FDA on **June 20, 2003**, atazanavir (Reyataz) marked a significant advancement in HIV treatment as the first once-daily protease inhibitor for adults. The answer to the question 'when was atazanavir FDA approved?' highlights a key moment in the evolution of antiretroviral therapy and the shift towards more convenient, patient-friendly dosing regimens.

Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir, formulated to deliver the active antiviral agent to target cells more efficiently and at a much lower dose than its predecessor, tenofovir disoproxil fumarate (TDF) [1.2.2]. The central question for clinicians and patients is: Is tenofovir alafenamide better than tenofovir disoproxil fumarate?

Elvitegravir is an antiretroviral medication approved by the U.S. FDA in 2012 for the treatment of HIV infection. By understanding **what type of drug is elvitegravir**, patients and healthcare providers can grasp its critical role in modern antiretroviral therapy (ART) and how it helps control the virus's replication.

On December 22, 2022, the FDA approved Sunlenca (lenacapavir), a groundbreaking, long-acting medication for heavily treatment-experienced adults living with multidrug-resistant HIV-1. This first-in-class capsid inhibitor offers a twice-yearly subcutaneous injection, revolutionizing treatment options for those with limited alternatives.

Single-dose Nevirapine (NVP) given to a mother and infant can reduce mother-to-child HIV transmission, with some studies showing a reduction in viral load of over 50% [1.9.1]. But for patients and caregivers, a crucial question remains: What are the side effects of NVP Syrup?